Home XinKainuo Medical's Intracranial Stent Gains NMPA Approval for Wide-Necked Aneurysm Treatment

XinKainuo Medical's Intracranial Stent Gains NMPA Approval for Wide-Necked Aneurysm Treatment

Jul 02, 2026 16:27 CST Updated 16:27
Skynor Medical

Vascular Minimally Invasive Intervention Product Developer

Source: National Medical Products Administration website

Recently, the National Medical Products Administration approved the registration application for the innovative product “Intracranial Stent” from Skynor Medical (Shanghai) Co., Ltd.

The product consists of a stent and a delivery system, designed to be used in conjunction with embolization devices for the treatment of wide-necked saccular aneurysms in the anterior circulation of the intracranial arteries. The stent features a closed-cell helical wire interlocking design, a closed-loop structure, and full radiopacity, intended to provide excellent flexibility and wall apposition, allow for recapture and repositioning, and ensure accurate stent placement.

The drug regulatory authorities will strengthen post-market supervision of this product to ensure the safety of patients using medical devices.